← Back to blog

What Does End-of-Life Care Look Like for Ovarian Cancer?

By CRYSTAL BAI

What Does End-of-Life Care Look Like for Ovarian Cancer?

The short answer: End-of-life care for ovarian cancer focuses on managing abdominal symptoms — ascites (fluid buildup), bowel obstruction, pain, and fatigue — alongside the profound psychological dimensions of a disease that often presents late. Most women with recurrent, platinum-resistant ovarian cancer transition to hospice when progressive disease no longer responds to treatment, typically in final weeks to months.

Ovarian cancer is called "the silent killer" because it often presents in advanced stages (Stage III or IV) when symptoms are vague — bloating, pelvic discomfort, early satiety. While first-line treatment (surgery and carboplatin/paclitaxel chemotherapy) achieves remission in most cases, recurrence is common and each subsequent line of treatment has diminishing efficacy. When platinum-resistant recurrent disease no longer responds to therapy, the focus shifts to comfort-centered care.

How Ovarian Cancer Progresses to End Stage

Ovarian cancer typically spreads within the abdominal and pelvic cavity (peritoneal spread) before metastasizing to liver, lungs, and lymph nodes. The peritoneal spread creates the most challenging end-of-life symptoms: malignant ascites (fluid accumulation in the abdomen), malignant bowel obstruction from peritoneal implants, and widespread abdominal disease causing pain and nausea. For some women, ascites and bowel obstruction are the primary end-of-life challenges.

Malignant Ascites

Malignant ascites — fluid produced by peritoneal tumor implants — causes abdominal distension, discomfort, early satiety, dyspnea (from diaphragm elevation), and nausea. Management options: Paracentesis — drainage of ascitic fluid through a needle or catheter, providing temporary relief (hours to weeks). Repeated paracentesis is common. Permanent peritoneal catheter (e.g., PleurX catheter) — allows families to drain ascites at home, reducing repeated hospital visits and providing ongoing comfort. This is an excellent palliative option. Diuretics have limited efficacy for malignant ascites.

Malignant Bowel Obstruction

Bowel obstruction from peritoneal disease is one of the most feared complications of advanced ovarian cancer. Surgical correction is often not appropriate in end-stage disease. Medical management includes: octreotide (reduces GI secretions), corticosteroids (reduce inflammation and obstruction), antiemetics (manage nausea), opioids (manage pain and cramping), and nasogastric suction in severe cases. The decision about whether to pursue a venting gastrostomy tube versus purely medical management should be made with palliative care guidance and in alignment with the patient's goals.

Emotional and Psychological Dimensions

Ovarian cancer disproportionately affects women in their 50s-70s who are at significant life stages — often with children, grandchildren, careers, and ongoing contributions they wish to continue making. The recurrent nature of ovarian cancer — cycles of treatment, remission, and progression — creates a distinctive grief pattern: women and families may experience anticipatory grief repeatedly over years of illness. Death doulas and palliative care social workers can provide invaluable support in navigating this grief pattern and in articulating values-based end-of-life decisions.

Hospice for Ovarian Cancer

Hospice is appropriate when ovarian cancer has become platinum-resistant and no further chemotherapy, targeted therapy, or immunotherapy is expected to provide meaningful quality of life benefit, and life expectancy is estimated at six months or less. Home hospice with palliative drainage expertise (for ascites and pleural effusions) can provide excellent comfort. Many women with ovarian cancer benefit significantly from a PleurX catheter for home drainage alongside hospice enrollment.

Frequently Asked Questions

What are the end-stage symptoms of ovarian cancer?

End-stage ovarian cancer symptoms include malignant ascites (abdominal fluid causing bloating, discomfort, and dyspnea), malignant bowel obstruction (causing pain, nausea, and inability to eat), profound fatigue, weight loss, and pain from peritoneal and organ involvement. These symptoms can usually be well-managed with expert palliative and hospice care including home drainage for ascites.

What is a PleurX catheter for ovarian cancer?

A PleurX catheter is a permanent drainage catheter placed in the abdomen (or chest) to allow drainage of recurring malignant fluid (ascites or pleural effusion) at home. It eliminates the need for repeated hospital paracentesis visits. For women with end-stage ovarian cancer who produce large amounts of ascitic fluid, a PleurX catheter dramatically improves quality of life and comfort.

Is bowel obstruction common in end-stage ovarian cancer?

Yes. Malignant bowel obstruction from peritoneal tumor implants is one of the most common and challenging complications of advanced ovarian cancer. It causes pain, nausea, vomiting, and inability to eat. In end-stage disease, medical management (octreotide, corticosteroids, antiemetics, opioids) rather than surgery is usually most appropriate. Palliative care specialists are essential in managing this complication.

When should someone with ovarian cancer enter hospice?

Hospice for ovarian cancer is appropriate when the cancer has become platinum-resistant and no further treatment is expected to meaningfully improve quality of life, life expectancy is estimated at six months or less, and the primary goal is comfort. Early hospice enrollment allows time to arrange home drainage options (PleurX catheter), manage symptoms proactively, and support the family before crisis.

What is the difference between platinum-sensitive and platinum-resistant ovarian cancer?

Platinum-sensitive ovarian cancer recurs more than 6 months after completing platinum-based chemotherapy and typically responds to repeat platinum treatment. Platinum-resistant ovarian cancer recurs within 6 months of platinum treatment and has much lower response rates to subsequent therapies. Platinum resistance is a key inflection point where the focus increasingly shifts toward quality of life and eventually hospice care.


Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.